|
4th International AIDS Society Conference on HIV Pathogenesis and TreatmentSydney, Australia - July 22 - 25, 2007 |
CO-INFECTION OF STDS WITH HIV AMONG MEN WHO HAVE SEX WITH MEN IN BEIJING, CHINA
IAS Conf HIV Pathog Treat 2007 Jul 22-25;4th: Abstract No. MOAC102
Zhang X.X.1, Wang C.1, Wang H.1, Li D.1, Zhang X.Y.2, Shao Y.3
1Chaoyang District CDC, Beijing, China, 2Chinese National Center for AIDS/STD Control and Prevention, Virology and Immunology, Beijing, China, 3State Key Laboratory for Infectious Disease Prevention and Control,Chinese National Center for AIDS/STD Control and Prevention, Beijing, China
OBJECTIVE(S): To investigate the co-infection sexually transmitted infections (STDs) with HIV among MSM.
METHODS: MSM were recruited at a voluntarily counseling testing (VCT) clinic, and sera samples were collected for testing HIV and co-infection of STDs as well as HCV and Toxoplasma. 753 MSM were recruited between January 2005 and December 2006 through the VCT clinic at Chaoyang District CDC in Beijing. Sera samples were collected for testing HIV, Syphilis, Ureaplasma Urealyticum (UU), Chlamydia Trachomatis (CT ), HCV and Toxoplasma gondii. Statistical analyses were performed to identify factors related to STD infection, and co-infection with HIV.
RESULTS: Prevalence of HIV-1 infection among MSM attending the VCT clinic was 2.12%. Seven per cent had syphilis, 5.58% had Chlamydia, 4.38% had UU, 2.52% had Toxoplasma and 0.8% had HCV; the total infection rate of these five conditions was 13.28%. Among HIV-negative MSM the co-infection rate was 11.94%, and among HIV-positive MSM it was 93.75%.
CONCLUSIONS: The co-infection rate was much higher in HIV-positive MSM compared with those in HIV- MSM population. HIV-positive men were most frequently coinfected with syphilis. The data suggest that the strategy for HIV/AIDS prevention and control among MSM should be combined with STDs in China.
Download PDF of this abstract.
Download Power Point Presentation.
2007-07-22
MOAC102
STI Treatment for HIV Prevention
Copyright © 2007 - International AIDS Society (IAS). All information and content relating to the abstracts from the 3rd International AIDS Society Conference on HIV Pathogenesis and Treatment, such as text, graphics, logos, button icons, images, audio clips, and software is protected by copyright. Permission is hereby granted for the non-commercial use or reproduction of the information on this web site, provided that the use of such information is accompanied by an acknowledgement that IAS is the source of the information and the name of the author of the article.
AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2007. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2007. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. Permission is hereby granted for the non-commercial use or reproduction of the information herein, provided that the use of such information is accompanied by an acknowledgement that IAS is the source of the information and the name of the author of the article.